New Haven, CT11 Active Studies

Type 1 Diabetes Clinical Trials in New Haven, CT

Find 11 actively recruiting type 1 diabetes clinical trials in New Haven, CT. Connect with local research sites and explore new treatment options.

11
Active Trials
6
Sponsors
1,708
Enrolling

Recruiting Type 1 Diabetes Studies in New Haven

NCT07088068Recruiting

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insul...

New Haven, CTPHASE3723 participantsSanofi
View Study Details
NCT06481904Recruiting

Registry for Stage 2 Type 1 Diabetes

Stage 2 Type 1 Diabates (T1D) is an early stage of T1D characterized by dysglycemia but not yet leading to clinical symptoms. Progression of the disease to Stage 3 (clinical T1D), leads to overt hyper...

New Haven, CT200 participantsSanofi
View Study Details
NCT05762107Recruiting

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

The goal of this clinical trial is to learn about the effect of the study drug (ZT-01) on low blood sugar (hypoglycemia) in adults with type 1 diabetes (T1D) who have been having low blood sugars ("hy...

New Haven, CTPHASE2186 participantsZucara Therapeutics Inc.
View Study Details
NCT07061574Recruiting

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

This multi-center randomized controlled trial will assess the safety and efficacy of ATG followed by either adalimumab or verapamil in preserving insulin secretion 2 years from randomization in person...

New Haven, CTPHASE1120 participantsCity of Hope Medical Center
View Study Details
NCT02734277Recruiting

Type 1 Diabetes Extension Study

This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodula...

New Haven, CT111 participantsNational Institute of Allergy and Infectious Diseases (NIAID)
View Study Details
NCT07224321Recruiting

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

INHALE-1st is a Phase 2, single-arm, multi-center, clinical study evaluating the safety and efficacy of Afrezza in combination with subcutaneously-injected basal insulin (BI) for youth 10 to \<18 year...

New Haven, CTPHASE2100 participantsMannkind Corporation
View Study Details
NCT07059806Recruiting

T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes

Randomized controlled trial with a wait list control arm. Participants will be randomized 1:1 to T1CARE or wait list usual care arm. Participants will be recruited from the Yale Adult and Pediatric Di...

New Haven, CTNA100 participantsYale University
View Study Details
NCT06967701Recruiting

Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes

The challenges of living with type 1 diabetes often stand in the way of getting enough exercise. Continuous blood sugar monitoring has revolutionized type 1 diabetes care but remains underutilized to ...

New Haven, CTNA60 participantsYale University
View Study Details
NCT07155252Recruiting

Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening

This study aims at quantifying the accuracy of a self-administered fingerstick based glucose tolerance test (GTT@Home) respect to the gold-standard in-clinic venous plasma measures during the oral glu...

New Haven, CT60 participantsYale University
View Study Details
NCT06171412Recruiting

Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use

This is a study to develop and evaluate a peer mentoring intervention for Black and Latinx adolescents with type 1 diabetes to increase the initiation and maintenance of a continuous glucose monitorin...

New Haven, CTNA38 participantsYale University
View Study Details
NCT07062887Recruiting

Digital Mindfulness for Young Adults With Type 1 Diabetes

The purpose of this research study is to test a mindfulness app called Calm Health among young adults with type 1 diabetes or other absolute insulin deficiency diabetes. Mindfulness is the practice of...

New Haven, CTNA10 participantsYale University
View Study Details

About Type 1 Diabetes Clinical Trials in New Haven

Type 1 diabetes is an autoimmune condition where the immune system destroys insulin-producing beta cells in the pancreas. It typically develops in childhood or young adulthood and requires lifelong insulin therapy. Research is exploring artificial pancreas systems, immunotherapy, and beta cell replacement.

There are currently 11 type 1 diabetes clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 1,708 participants. Research is being sponsored by Sanofi, Zucara Therapeutics Inc., City of Hope Medical Center and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Type 1 Diabetes Clinical Trials in New Haven — FAQ

Are there type 1 diabetes clinical trials in New Haven?

Yes, there are 11 type 1 diabetes clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What type 1 diabetes treatments are being tested?

The 11 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for type 1 diabetes.

Data updated July 19, 2026 from ClinicalTrials.gov